Periodontitis and type 2 diabetes: Is oxidative stress the mechanistic link?

Scottish Medical Journal

Volumn 54, Issue 2, 2009, Pages 41-47

  Allen, E M ^a   Matthews, J B ^b   O'Connor, R ^c   O'Halloran, D ^d   Chapple, I L C ^b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b BIRMINGHAM DENTAL HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE CORK   (Ireland)

^d University College Cork and INFANT Centre   (Ireland)

Author keywords

Diabetes; Inflammation; Oxidative stress; Periodontitis

Indexed keywords

ACETYLCYSTEINE; ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; FREE RADICAL; REACTIVE OXYGEN METABOLITE; THIOCTIC ACID;

ANTIOXIDANT ACTIVITY; COMORBIDITY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETOGENESIS; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GLYCEMIC CONTROL; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INSULIN RESISTANCE; METABOLIC REGULATION; MOUTH HYGIENE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOGENESIS; PERIODONTITIS; REVIEW; SIGNAL TRANSDUCTION; METABOLISM; PATHOLOGY; PHYSIOLOGY;

DIABETES MELLITUS, TYPE 2; HUMANS; OXIDATIVE STRESS; PERIODONTITIS;

EID: 67651219372     PISSN: 00369330     EISSN: None     Source Type: Journal    
DOI: 10.1258/rsmsmj.54.2.41     Document Type: Review

References (98)

1. Cohen DW, Friedman LA, Shapiro J, Kyle JC, Franklin S. Diabetes mellitus and Periodontal Disease: Two year longitudinal observations. J Periodontol 1970; 41: 709-712.
2. Nelson RG, Shlossman M, Budding LM et al. Periodontal disease and NIDDM in Pima Indians. Diabetes Care 1990; 13: 836-840.
3. Seppala B, Seppala M, Ainamo J. A longitudinal study on insulin-dependent diabetes mellitus and periodontal disease. J Clin Perio 1993: 20:161-165.
4. Firatli E. The relationship between clinical periodontal status and insulin-dependent diabetes mellitus. Results after 5 years. J Periodontol 1997; 68:136-140.
5. Taylor GW, Burt BA, Becker MP, Genco RJ, Shlossman M. Non-insulin dependent diabetes mellitus and alveolar bone loss progression over 2 years. J Periodontol 1998; 69: 76-83.
6. Sandberg GE, Sundberg HE, Fjellstrom CA, Wikbled KF. Type 2 diabetes and oral health: A comparison between diabetic and non-diabetic subjects. Diab Res Clin Prac 2000; 50: 27-34.
7. Tsai C, Hayes C, Taylor GW. Glycaemic control of type 2 diabetes and severe periodontal disease in the US adult population. Comm Dent Oral Epidem 2002; 30: 182-192.
8. Marugame T. Alveolar bone loss associated with glucose tolerance in Japanese men. Diabet Med 2003; 20: 746-751.
9. Tervonen T, Oliver RC. Long-term control of diabetes and periodontitis. J Clin Perio 1993; 20: 431-435.
10. Collin HL, Uusitua M, Niskanen L et al. Periodontal findings in elderly patients with non-insulin dependent diabetes mellitus. J Periodontol 1998; 69: 962-966.
11. Grossi SG, Skrepcinski FB, DeCaro T et al. Treatment of periodontal disease in diabetics reduces glycated haemoglobin. J Periodontol 1997; 68: 713-719.
12. Rodrigues DC, Taba MJ, Novaes AB, Souza SL, Grisi MF. Effect of non-surgical periodontal therapy on glycaemic control in patients with type 2 diabetes mellitus. J Periodontol 2003; 74: 1361-1367.
13. Stewart JE, Wager KA, Friedlander AM, Zader HH. The effect of periodontal treatment on glycaemic control in patients with type 2 diabetes mellitus. J Clin Perio 2001; 28: 306-310.
14. Kiran M, Arpak N, Unsal E, Erdogan MF. The effect of improved periodontal health on metabolic control in type 2 diabetes mellitus. J Clin Perio 2005; 32: 266-272.
15. Navarro-Sanchez AB, Faria-Almeida R, Bascones-Martinez A. Effect of non-surgical periodontal therapy on clinical and immunological response and glycaemic control in type 2 diabetic patients with moderate periodontitis. J Clin Perio 2007; 34: 835-43.
16. Taylor GW. Bidirectional interrelationships between diabetes and periodontal diseases; an epidemiologic perspective. Ann Periodontol 2001; 61: 99-112.
17. Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med 91 1991; (suppl 3C): 14S-22S.
18. Battino M, Bullon P, Wilson M, Newman H. Oxidative injury and inflammatory periodontal diseases: the challenge of anti-oxidants to free radicals and reactive oxygen species. Crit Rev Oral Biol Med 1999; 10: 458-476.
19. Genestra M. Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell Signal. 2007; 19:1807-19
20. Halliwell B. Antioxidants in Human Health and Disease. Annu Rev Nutr 1996; 16: 33-50.
21. Frei B. Molecular and biological mechanisms of antioxidant action. FASEB J 1999; 13: 963-964.
22. Chapple ILC. Reactive oxygen species and antioxidants in inflammatory diseases. J Clin Perio 1997; 24: 287-296.
23. Waddington RJ, Moseley R, Embery G. Reactive Oxygen Species: a potential role in the pathogenesis of periodontal diseases. Oral Diseases 2000; 6: 138-151.
24. Pinkus R, Weiner LM, Daniel V. Role of Oxidants and Antioxidants in the Induction of AP-1, NF-kappa B, and Glutathione S-Transferase Gene Expression. J Biol Chem 1996; 271: 13422-13429.
25. Hayden MS, Ghosh S. Signaling to NF-[kappa]B. Genes Dev 2004; 18: 2195-2224.
26. Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 2004; 142: 231-255.
27. Yeum KJ, Russell RM, Krinsky,NI, Aldini G. Biomarkers of antioxidant capacity in the hydrophilic and lipophilic compartments of human plasma. Arch Biochem Biophys 2004; 430: 97-103.
28. Chapple ILC, Mason GM, Matthews JB, Thorpe GHG, Maxwell SRJ, Whitehead T. Enhanced chemiluminescent assay for measuring the total antioxidant capacity of serum, saliva and crevicular fluid. Ann Clin Biochem 1997; 34: 412-421.
29. Socransky SS, Haffajee AD. Periodontal microbial ecology. Periodontol 2000 2005; 38:135-187.
30. Petersen PE, Bourgeois D, Ogava H, Estupinan-Day S, Ndiaye C. The global burden of oral diseases and risks to oral health. Bull WHO 2005; 83:661-9.
31. Teng Y. The role of acquired immunity and periodontal disease progression. Crit Rev Oral Biol Med 2003; 14: 237-252.
32. Noack B, Genco RJ, Trevison M et al. Periodontal infections contribute to elevated systemic C-rective protein. J Periodontol 2000; 72: 1221-1227.
33. Al-Shammari KF. Risk indicators for tooth loss due to periodontal disease. J Periodontol 2005; 76: 1910-8.
34. Kornman KS, Page RC, Tonetti MS. The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000 1997; 14: 33-35.
35. Segal A. How neutrophils kill microbes. Ann Rev Immunol 2005; 23:197-223.
36. Katsuragi H, Ohtake M, Kurasawa I, Saito K. Intracellular production and extracellular release of oxygen radicals by PMNs and oxidative stress on PMNs during phagocytosis of periodontopathic bacteria. Odontology 2003; 91: 13-18.
37. Chapple ILC, Matthews JB. The role of reactive oxygen and antioxidant species in periodontal tissue destruction. Periodontol 2000 2007; 43:160-232.
38. Fredriksson MI, Gustaffson AK, Bergstrom KG, Asman BE. Constitutionally hyperreactive neutrophils in periodontitis. J Periodontol 2003; 74: 219-224.
39. Matthews JB, Wright HJ, Roberts A, Cooper PR, Chapple ILC. Hyperactivity and reactivity of peripheral blood neutrophils in chronic periodontitis. Clin Exp Immunol. 2007; 147: 255-64.
40. Matthews JB, Wright HJ, Roberts A et al. Neutrophil hyperreponsiveness in periodonitis. J Dent Res 2007; 86: 718-22.
41. Wright HJ, Cooper PR, Chapple ILC, Matthews JB. Differential gene expression of neutrophils in chronic periodontitis. J Dent Res 2005; 84(Spec Iss B): 14.
42. Chapple IL, Milward MR, Dietrich T. The prevalence of inflammatory periodontitis is negatively associated with serum antioxidant concentrations. J Nutr 2007; 137: 657-64.
43. Brock GR, Matthews JB, Butterworth CJ, Chapple ILC. Local and systemic total antioxidant capacity in periodontitis and health. J Clin Perio 2004; 31: 515.
44. Chapple ILC, Brock GR, Milward MR, Ling N, Matthews JB. Compromised GCF total antioxidant capacity in periodontitis: cause or effect? J Clin Perio 2007; 34: 103-110.
45. Akalin FA, Toklu E, Renda N. Analysis of superoxide dismutase activity levels in gingiva and gingival crevicular fluid in patients with chronic periodontitis and periodontally healthy controls. J Clin Perio 2005; 32: 238-243.
46. Sugano N, Kawamoto K, Numazaki H, Murai S, Ito K. Detection of mitochondrial DNA mutations in human gingival tissues. J Oral Sci 2000; 42: 221-223.
47. Takane M, Sugano N, Ezawa N, Uchiyama T, Ito K. A marker of oxidative stress in saliva: association with periodontally-involved teeth of a hopeless prognosis. J Oral Sci 2005; 47: 53-57.
48. Di Paulo R, Mazzon E, Rotondo F et al. Reduced development of experimental periodontitis by treatment with M40403, a superoxide dismutase mimetic. Eur J Pharmacol. 2005; 516: 151-7.
49. Panjamurthy K, Manoharan S, Ramachandran CR. Lipid peroxidation and antioxidant status in patients with periodontitis. Cell Molec Biol Lett 2005: 10: 255-264.
50. Sculley DV, Langley-Evans SC. Periodontal disease is associated with lower antioxidant capacity in whole saliva and evidence of increased protein oxidation. Clin Sci (Lond). 2003; 105: 167-72.
51. Tomofuji T, Ekuni D, Yamanaka R et al. Chronic administration of lipopolysaccharide and proteases induces periodontal inflammation and hepatic steatosis in rats. J Periodontol 2007; 78: 1999-2006.
52. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2004; 27: 5S-10.
53. Almind K, Doric A, Kahn CR. Putting the genes for type 2 diabetes on the map. Nat Med 2001; 7: 277-279.
54. Ford ES. Risks for All-Cause Mortality, Cardiovascular Disease, and Diabetes Associated With the Metabolic Syndrome: A summary of the evidence. Diabetes Care 2005; 28: 1769-1778.
55. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 2003: 46: 3-19.
56. Pickup JC. Inflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes. Diabetes Care 2004; 27: 813-823.
57. Borst SE. The role of TNF-alpha in Insulin Resistance. Endocrine 2004; 23: 77-82.
58. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signalling pathways: a unifying hypothesis of type 2 diabetes. Endo Rev 2002; 23: 599-622.
59. Ceriello A, Motz E. Is Oxidative Stress the Pathogenic Mechanism Underlying Insulin Resistance, Diabetes, and Cardiovascular Disease? The Common Soil Hypothesis Revisited. Arterioscler Thromb Vasc Biol 2004; 24: 816-823.
60. Gallou G, Ruellard A, Campion L et al. Increase in thiobarbituric acid reactive substances and vascular complications in type 2 diabetes mellitus. Diab Metab 1994; 20: 258-264.
61. Rehman A, Nourooz-Zadeh J, Moller W et al. Increased oxidative damage to all DNA bases in patients with type II diabetes mellitus. FEBBS Lett 1999; 448: 120-122.
62. Abahusain MA, Wright J, Dickenson JW, de Bol EB. Retinol, alpha-tocopherol and carotenoids in diabetes. Eur J Clin Nutr 1999; 53: 630-635.
63. Opara EC, Abdel-Rahman EC, Soliman S et al. Depletion of total antioxidant capacity in type 2 diabetes mellitus. Metabolism 1999; 48: 1414-1417.
64. Maxwell SRJ, Thomason H, Sandler D et al. Poor glycaemic control is associated with reduced serum free radical scavenging (antioxidant) activity in non-insulin-dependent diabetes. Ann Clin Biochem 1997; 34: 638-644.
65. Esposito K, Nappo F, Marfella R et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: Role of oxidative stress. Circulation 2002; 106: 2067-2072.
66. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820.
67. Green K, Brand, MD, Murphy MP. Prevention of Mitochondrial Oxidative Damage as a Therapeutic Strategy in Diabetes. Diabetes Care 2004; 53: s110-117.
68. Mohanty P, Hanouda W, Garg R et al. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endo Metab 2000; 85: 2970-2973.
69. Quagliaro L, Piconi L, Assaloni R et al. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: The role of Protein Kinase C and NAD(P)H-Oxidase activation. Diabetes 2003; 52: 2795-2804.
70. Gillery P, Monboisse JC, Maquart FX, Borel JP. Glycation of proteins as a source of superoxide. Diabet Metab 1998; 14: 25-30.
71. Kiritoshi S, Nishikawa T, Sonoda K et al. Reactive Oxygen Species from mitochondria induce Cyclooxygenase-2 gene expression in human mesangial cells: Potential role in diabetic nephropathy. Diabetes 2003; 52: 2570-2577.
72. Chen S, Mukherjee S, Chakraborty C, Chakraborti S. High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-kappa B and AP-1. Am J Physiol Cell Physiol 2003; 284: C263-272.
73. Romeo G, Liu WH, Asnaghi V, Kern TS, Lorenzi M. Activation of Nuclear Factor-{kappa}B induced by Diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 2002; 51: 2241-2248.
74. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006; 440: 944-8.
75. Sakai K, Matsumoto K, Nishikawa T et al. Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic beta-cells. Biochem Biophys Res Commun 2003; 300: 216-222.
76. Loe H. Periodontal Disease. The sixth complication of diabetes mellitus. Diabetes Care 1993; 16: 329-334.
77. Saito T, Shimazaki Y, Kiyohara Y et al. The severity of periodontal disease is associated with the development of Glucose Intolerance in Non-diabetics: The Hisayama Study. J Dent Res 2004; 83: 485-490.
78. Noma H, Sakamoto I, Mochizuki H et al. Relationship between periodontal disease and diabetic retinopathy. Diabetes Care 2004; 27: 615.
79. Losche W, Karapetow F, Pohl A, Pohl C, Kocher T. Plasma lipid and blood glucose levels in patients with destructive periodontal disease. J Clin Perio 2000; 27: 537-541.
80. Pontes Andersen CC, Flyvbjerg A, Buschard K, Holmstrup P. Periodontitis is associated with aggravation of prediabetes in Zucker fatty rats. J Periodontol. 2007; 78: 559-65.
81. Saremi A, Nelson RG, Tulloch-Reid M et al. Periodontal Disease and mortality in Type 2 Diabetes. Diabetes Care 2005; 28: 27-32.
82. Shultis WA, Weil EJ, Looker HC et al. Effect of periodontitis on overt nephropathy and end-stage renal disease in Type 2 Diabetes. Diabetes Care. 2007; 30: 306-11.
83. Iacopino AM. Periodontitis and Diabetes Interrelationships: Role of Inflammation. Annals Periodontol 2001; 6: 125-137.
84. Duarte PM, de Oliveira MC, Tambeli CH et al. Overexpression of interleukin-1beta and interleukin-6 may play an important role in periodontal breakdown in type 2 diabetic patients. J Perio Res. 2007; 42: 377-81.
85. Engebretson S, Chertog R, Nichols A et al. Plasma levels of tumour necrosis factor-alpha in patients with chronic periodontitis and type 2 diabetes. J Clin Perio 2007; 34: 18-24.
86. Karima M, Kantarci A, Ohira T et al. Enhanced superoxide release and elevated protein kinase C activity in neutrophils from diabetic patients: association with periodontitis. J Leuk Biol 2005; 78: 862-870.
87. Schmidt AM, Weidman E, Lalla E et al. Advanced Glycation Endproducts (AGEs) induce oxidant stress in the gingiva: A potential mechanism underlying accelerated periodontal disease associated with diabetes. J Perio Res 1996; 31: 508-515.
88. Katz J, Bhattacharyya I, Farkhondeh-Kish F et al. Expression of the receptor of advanced glycation end products in gingival tissues of type 2 diabetes patients with chronic periodontal disease: a study utilizing immunohistochemistry and RT-PCR. J Clin Perio 2005; 32: 40-4.
89. Monboisse JC. In-vitro glycoxidation alters the interactions between collagens and polymorphonuclear leucocytes. Biochem J 2000; 350: 777-783.
90. Palmer RM, Wilson RF, Hasan AS, Scott DA. Mechanisms of action of environmental factors-tobacco smoking. J Clin Perio 2005; 32 Suppl 6: 180-95.
91. Cerami C, Founds H, Nicholl I et al. Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci U S A. 1997; 94:13915-20.
92. Dickerson TJ, Janda KD. A previously undescribed chemical link between smoking and metabolic disease. Proc Natl Acad Sci U S A. 2002; 99:15084-8.
93. Katz J. Receptor for advanced glycation end-product (RAGE) upregulation in human gingival fibroblasts incubated with nornicotine. J Periodontol 2005; 76: 1171-1174.
94. Ceriello A. New Insights on Oxidative Stress and Diabetic Complications May Lead to a "Causal" Antioxidant Therapy. Diabetes Care 2003; 26: 1589-1596.
95. Borcea V, Nourooz-Zadeh J, Wolff SP et al. Alpha-lipoic acid decreases oxidative stress even in diabetic patients with poor glycaemic control. Free Radic Biol Med 2005; 26: 1495-1500.
96. Ziegler D, Harefeld M, Ruhnass KJ et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 1999; 22: 1296-1301.
97. Stolarek R, Bialasiewicz P, Novak D. N-Acetylcysteine effect on the luminol-dependent chemiluminescence pattern of Reactive Oxygen Species generation by human polymorphonuclear leukocytes. Pulm Pharm Ther 2002; 15: 385-392.
98. Di Paola R, Marzocco S, Mazzon E et al. Effect of Aminoguanidine in ligature-induced periodontitis in rats. J Dent Res 2004; 83: 343-348.